Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy

Leukemia & lymphoma/Leukemia and lymphoma 2026

View at publisher
Authors: Daniela Estefania Banegas, Isacco Ferrarini, Andrea Bernardelli, Alessia Moioli, Vittorio Ruggero Zilioli, Luca Nassi, Chiara Rusconi, Beatrice Casadei, Cinzia Pellegrini, Guido Gini, Giuseppe Gritti, Giulia Daghia
+19 more Elsa Pennese, Luigi Petrucci, Simone Ferrero, Sonya De Lorenzo, Sara Veronica Usai, Ausilia Gorgone, Massimo Gentile, Alessia Castellino, Anna Vanazzi, Luigi Curreli, Lucia Morello, Monica Tani, Daniela Renzi, Brunella Mola, Alberto Fabbri, A. Molteni, Roberta Sciarra, Pier Luigi Zinzani, C. Visco
DOI: 10.1080/10428194.2026.2621825
Cited by: 2
References: 11

Abstract

MCL is a rare subtype of B-cell non-Hodgkin lymphoma, accounting for approximately 5–7% of all lymphomas and showing a higher prevalence in males. MCL is characterized by the expression of CD5 and ...

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
Leukemia & lymphoma/Leukemia and lymphoma
Publisher
Informa UK Limited
Volume
67
Issue
6
Pages
1414–1418
Publication date
29 January 2026
Language
EN